Development of an MRI istrument based on magnetic nano particels, for the detection of singular cells.
Partners: Siemens AG (DE), Frauenhofer IZI (DE), TU Braunschweig (DE), nanoPet Pharma GmbH (DE), pluriSelect GmbH (DE), AIT GmbH (AT), Bioville GmbH (DE)
Genetically modified DCs
Partners: CCRI, I. Med. Onkologie, WSP
Comparison of different DC technologies (manufacture, antigens, administration)
Partners: IDM (FR), Uni Erlangen (DE), PeterMac Cancer Institute (AU), Etna Biotech (IT), ISS (IT)